-mapimod
Drugs that block MAP kinases.
- Drugs ending in -mapimod: 11
- Approved somewhere: 0
- With a US drug page: 0
Approved and clinical-stage drugs in ChEMBL whose names ending in -mapimod, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Losmapimod | Phase 3 | MAPK14, MAPK11 | MAP kinase p38 alpha inhibitor |
| Acumapimod | Phase 2 | MAPK14 | MAP kinase p38 alpha inhibitor |
| Bentamapimod | Phase 2 | c-Jun N-terminal kinase, JNK | c-Jun N-terminal kinase, JNK inhibitor |
| Dilmapimod | Phase 2 | MAPK14 | MAP kinase p38 alpha inhibitor |
| Doramapimod | Phase 2 | MAPK14 | MAP kinase p38 alpha inhibitor |
| Neflamapimod | Phase 2 | MAPK14 | MAP kinase p38 alpha inhibitor |
| Semapimod | Phase 2 | MAPK14 | MAP kinase p38 alpha inhibitor |
| Talmapimod | Phase 2 | MAPK14 | MAP kinase p38 alpha inhibitor |
| Emprumapimod | Phase 1 | — | — |
| Balamapimod | — | MAP2K1, MAP2K2 | Dual specificity mitogen-activated protein kinase kinase 1 inhibitor |
| Pamapimod | — | MAPK14 | MAP kinase p38 alpha inhibitor |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO